Allergen-specific immunotherapy: State of the art

• Egile Nagusiak: Roberto Bernardini (Egilea), Diego G. Peroni (Egilea), Pasquale Comberiati (Egilea), Serena Gracci (Egilea)
• Formatua: Liburua
• Argitaratua: Elsevier, 2024-03-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Allergen-specific immunotherapy (AIT) was born in 1911 and great progress has been made over the last 110 years, from the invention of subcutaneous and sublingual administration to new strategies. It can be applied in respiratory allergies, such as rhinoconjunctivitis and asthma, with even long-term...